Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Germline Genetic Testing of the TP53 Gene: Identification, Characterization, and Management of Patients and Families at High Risk of Cancer

NCT07419893 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.

NCT NCT07419893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07419893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Germline Genetic Testing of the TP53 Gene: Identification, Characterization, and Management of Patients and Families at High Risk of Cancer
Lead sponsor
European Institute of Oncology
Phase
Observational
Overall status
Recruiting
Start date
January 29, 2026
Completion date
January 31, 2031
Enrollment
1,940 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multi-gene transcriptional profiling, tp53 gene germline mutation carrier, tp53 gene mutation